Ligand Pharmaceuticals Inc.(纳斯达克:LGND)今日盘中股价大涨6.32%,引发市场广泛关注。根据相关报道,LGND公司2024年第四季度财报数据超出分析师预期,成为推动股价上涨的主因。
具体来看,LGND2024Q4调整后每股收益为1.27美元,高于分析师预估的1.19美元,同比下滑7.97%;季度销售额达4281万美元,亦超出分析师3902万美元的预期值,同比增长52.35%。业绩超预期证明公司发展实力强劲,增强了投资者对其未来发展的信心。
总的来说,LGND今日股价大涨与其财报业绩表现优异有直接关系,业绩超预期成为助推股价上行的主导力量。投资者乐观看好该公司未来发展前景,推动了LGND股价在盘中出现大涨行情。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.